How did Macrogenics' revenue streams shift in Q3 2024?
5/8/2025 05:24am
Aime
Macrogenics' revenue streams in Q3 2024 were primarily driven by Collaborative Agreements, which generated the highest revenue at $118.86 million. The company also had significant revenue from Product Revenue, Net, and Contract Manufacturing. The shift in revenue streams indicates Macrogenics' diversified business model and its ability to generate income through multiple channels1.
MGNX Revenue By Business
Date | Business Composition | Revenue By Business |
|---|---|---|
| 20240101-2024 | Government Agreements | 1.42M |
| 20240101-2024 | Government Agreements | 851.00K |
| 20240101-2024 | Government Agreements | 358.00K |
| 20240101-2024 | Contract Manufacturing | 2.28M |
| 20240101-2024 | Product Revenue, Net | 4.86M |
| 20240101-2024 | Collaborative Agreements | 1.45M |
| 20240101-2024 | Government Agreements | 358.00K |
| 20240101-2024 | Royalty | 160.00K |
Name |
|---|
| MacrogenicsMGNX |
| MacrogenicsMGNX |
| MacrogenicsMGNX |
| MacrogenicsMGNX |
| MacrogenicsMGNX |
| MacrogenicsMGNX |
| MacrogenicsMGNX |
| MacrogenicsMGNX |
Source:
1.
MGNX Revenue by Business in Q3 2024
Continue this conversation 
Explore
Screener
Analysis
Wiki